Company: IXHL
Filing Date: 2025-04-28
Form Type: 424B3
Source: 0001213900-25-036065
Chunk: 35

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-28
Form: 424B3
Chunk 35
---
may be applicable to any then outstanding preferred stock, holders of Common Stock are entitled to receive ratably those dividends, if
any, as may be declared by the board of directors out of legally available funds. In the event of our liquidation, dissolution or winding
up, the holders of Common Stock will be entitled to share ratably in the assets legally available for distribution to stockholders after
the payment of or provision for all of our debts and other liabilities, subject to the rights of any preferred stock then outstanding.
Holders of Common Stock have no preemptive or conversion rights or other subscription rights and there are no redemption or sinking funds
provisions applicable to the Common Stock. All outstanding shares of Common Stock are, and the Common Stock to be outstanding upon the
closing of this offering will be, duly authorized, validly issued, fully paid and nonassessable. The rights, preferences and privileges
of holders of Common Stock are subject to and may be adversely affected by the rights of the holders of shares of any series of preferred
stock that we may designate and issue in the future.

Transfer Agent and Registrar

The transfer agent and registrar
for our Common Stock is Computershare Trust Company, N.A. The transfer agent and registrar’s address is 150 Royall St., Canton,
Massachusetts 02021.

Stock Exchange Listing

Our Common Stock is listed for trading on Nasdaq
under the symbol “IXHL.”

<div align='center'>14</div>

Preferred Stock

As of April 11, 2025, there
were no shares of our preferred stock outstanding. Under the terms of our Certificate of Incorporation, our board of directors has the
authority, without further action by our stockholders, to issue up to 10,000,000 shares of preferred stock in one or more series, to establish
from time to time the number of shares to be included in each such series, to fix the designations, powers, preferences, and relative,
participating, optional or other rights, if any, of the shares of each wholly unissued series and any qualifications, limitations or restrictions
thereon, and to increase or decrease the number of shares of any such series, but not below the number of shares of such series then outstanding.

Our board of directors may
authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights
of the holders of Common Stock. The issuance of preferred stock, while providing flexibility in connection with